Skip to content

Sunday, October 26, 2025

Latest:

Social Media’s impact on children
Dr. Rafael Tomoya Michita named 2025 STAT Wunderkind
Healthy Habits: Dr. Olivia Ginnard enjoys yoga, walking
Not cosmetic: How a breast implant saved a life
Some human GII.4 norovirus infect cells better than others; researchers have found an explanation

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

poziotinib

A potentially more effective treatment for HER2 mutant metastatic breast cancer

June 23, 2022 Breast Cancer, cancer treatment, HER2 mutations, lobular breast cancer, Metastasis, neratinib, poziotinib, Research

A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.

From the Labs: Image of the Month

From the Labs: Neurons in a Huntington’s brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951